Sales revenues for September 2013

Sopharma AD (the “Company”) notifies that for September 2013 the Company realized an increase of sales revenues of 12% compared to the same period of 2012, including 17% increase of domestic sales and 10% increase of export sales.

During the past nine months Sopharma AD recorded a decrease of sales revenues of 1%, including 6% increase of domestic sales and 3% decrease of export sales compared to the same period of 2012.